Aims: The study investigates the influence of gestational age (GA), Apgar, pH-value, blood pressure and indicators for infection on the success of indomethacin in closing a PDAMethods: All 118 preterm infants treated with indomethacin between 1997–2002 sorted in following therapeutic outcome groups: Success: A haemodynamic sig. PDA was closed by (maybe multiple) treatments with indomethacin or became haemodynamic not sig. At the end of the observation period the PDA was closed. Non-success: A haemodynamic sig. PDA was not closed by (maybe multiple) application of indomethacin. At the end of the observation period the PDA was haemodynamic significant. A logistic model was created to analyse GA, Apgar 10min, minimal pH-value of the day indomethacin was started, elevated CRP as indicator for infection, maximal CRP-value, microbiol growth, endotracheal colonisation with Ureaplasma urealyticum (Uu) and blood pressure. To account for the age dependency of blood pressure a new variable (MAD-deviation) was calculated: The MAD deviation is the difference of mean arterial pressure from the reference value which corresponds to the weeks of GA.Results: 85 (72%) of the 118 preterm infants were treated successfully, 22 (19%) of the 33 treatment failures received surgical ligation, 5 died with PDA, 6 were transferred with PDA (3 because of NEC). Higher GA (p= 0,0001) and higher MAD-deviation (p= 0,04) increase the chance of a successful medical treatment (Odds Ratio (OR) 2,27/1,22). (Mean-Success 27,8± 2,3 weeks/10,3±6,6mmHg; Mean non-success 25,2±1,8 weeks/6,4±3,6mmHg). In non-success group the blood pressure amplitude was significant lower than in the success-group (16±4,8 mmHg vs. 20±6,3 mmHg; p= 0,0001).The chance of successful medical treatment will decrease if there is an endotracheal colonisation with Uu (p= 0,028/OR= 0,165). Surprisingly pos. microbiological cultures are associated with a higher success rate of indomethacin treatment (OR= 7,2/p= 0,011). No association with treatment outcome were found for pH, Apgar and CRP.Conclusion: Gestational age remains the main determining factor for success of indomethacin. The low mean arterial pressure in treatment failures might be indicative of a higher shunt volume. Chronic inflammation with Uu might cause prostaglandin activation which impedes the closure of the PDA. Taking these risk factors for treatment failure in account, might help in the decision whether to ligate the PDA surgically or try repeated courses of indomethacin.